Drug intelligence / Profile preview

OMS201

Development stage
Phase 1
Lead developer
Omeros
Modality
Small Molecules
Administration
Intravesical
01

Overview

OMS201 is an irrigation solution developed by Omeros Corporation for use during ureteroscopic procedures to remove urinary tract stones (urolithiasis). It is a proprietary combination of ketoprofen, a nonsteroidal anti-inflammatory drug (NSAID), and nifedipine, a calcium channel blocker. The solution is intended to be added to standard irrigation fluid during surgery to provide localized pharmacological effects. Ketoprofen inhibits cyclooxygenase enzymes (COX-1 and COX-2), reducing the synthesis of prostaglandins to manage pain and inflammation. Nifedipine acts as a smooth muscle relaxant by blocking L-type calcium channels, which helps prevent ureteral spasms and facilitates the passage or removal of stones.

02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)CACNA1C (Voltage-dependent L-type calcium channel subunit alpha-1C)

Beyond the preview

Go deeper on OMS201.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OMS201.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call